AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
OXALIPLATIN in Zimbabwe
6 products registered with MCAZ — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| OXALIGAL 100 SOLUTION; INFUSION | 2026/9.4/7436 | RHAEGAL PHARMACEUTICALS | active | 18 May 2031 |
| OXALIGAL 50 SOLUTION; INJECTION | 2026/9.4/7435 | RHAEGAL PHARMACEUTICALS | active | 18 May 2031 |
| OXALICAN 200 SOLUTION; INJECTION | 2026/9.4/7410 | RHAEGAL PHARMACEUTICALS | active | 23 Apr 2031 |
| OXALICAN 50 SOLUTION; INJECTION | 2026/9.4/7409 | RHAEGAL PHARMACEUTICALS | active | 23 Apr 2031 |
| OXOL SOLUTION; INJECTION | 2012/9.4/4718 | VENUS REMEDIES LTD | active | 17 Sept 2030 |
| OXOL INJECTABLE; INJECTION | 2017/9.4/5368 | VENUS REMEDIES LTD | active | 4 Feb 2029 |
OXALIPLATIN — MCAZ Registration Details
MCAZ (Zimbabwe) has 6 registered products containing OXALIPLATIN, of which 6 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track OXALIPLATIN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.